Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patient.
No data are available for the kinetics of anti-Hepatitis C Virus (HCV) antibodies in HIV/HCV co-infected patients after sustained virological response (SVR). We present a case of a HIV/HCV co-infected patient, showing a significant anti-HCV antibodies decrease during therapy, who achieved a HCV seroreversion 3 years after SVR. Among them, antibodies to core protein, the most strongly antigenic protein showed significant decrease. Our results indicate an absence of antigenic stimulation suggesting a total clearance of HCV.
['Maylin|Sarah|S|', 'de Verdière|Nathalie Colin|NC|', 'Salmona|Maud|M|', 'Simon|François|F|', 'Delaugerre|Constance|C|']
D000328:Adult D000998:Antiviral Agents D015658:HIV Infections D006526:Hepatitis C D018937:Hepatitis C Antibodies D006801:Humans D008297:Male D016896:Treatment Outcome D019562:Viral Load
HIV HCV SVR anti-HCV antibodies Clearance